Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
  1. Home
  2. Publications
  3. Supplementary Table S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study

Supplementary Table S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study

Authors:
  • KHKenichi Harano
    Kenichi Harano
  • TNTakehiro Nakao
    Takehiro Nakao
  • Shin Nishio
    Shin Nishio
  • TKTakahiro Katsuda
    Takahiro Katsuda
  • KTKazuto Tasaki
    Kazuto Tasaki
  • KTKazuhiro Takehara
    Kazuhiro Takehara
  • TYTakanori Yokoyama
    Takanori Yokoyama
  • HFHideki Furuya
    Hideki Furuya
  • KHKyoko Hongo
    Kyoko Hongo
  • MAMasatoshi Asano
    Masatoshi Asano
  • TITakashi Ikeno
    Takashi Ikeno
  • MWMasashi Wakabayashi
    Masashi Wakabayashi

Open Access
Publisher website
Google Scholar
  • 15 October 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.34520117
Abstract
Supplementary Table 2. Chemotherapy response scores.
Keywords
  • GYNECOLOGICAL CANCERS
  • OVARIAN CANCER
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • SMALL MOLECULE AGENTS
  • DNA-REACTIVE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.